A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain

This publication has 35 references indexed in Scilit:

• The appropriateness of use of percutaneous transluminal coronary angioplasty in Spain
  International Journal of Cardiology, 2001
• Role of economic models in randomized clinical trials
  American Heart Journal, 1999
• Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels
  New England Journal of Medicine, 1998
• Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in Unstable Angina and Non–Q-Wave Myocardial Infarction
  New England Journal of Medicine, 1998
• European Survey on Cardiac Interventions: open-heart surgery, percutaneous transluminal coronary angioplasty and cardiac catheterization in 1993 A preliminary report by the Institute for Cardiac Survey of the European Academy of Sciences and Arts
  Cardiovascular Surgery, 1995
• Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
  New England Journal of Medicine, 1995
• Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)
  The Lancet, 1994
• In Search of Power and Significance: Issues in the Design and Analysis of Stochastic Cost-Effectiveness Studies in Health Care
  Medical Care, 1994
• Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations.
  BMJ, 1991
• Foundations of Cost-Effectiveness Analysis for Health and Medical Practices
  New England Journal of Medicine, 1977